Blackrock Health Sciences Trust 

The BlackRock Health Sciences Trust functions as a closed-end equity investment fund, initiated by BlackRock, Inc. and overseen by BlackRock Advisors, LLC. This trust primarily allocates capital to publicly traded companies within the United States' health sciences and related sectors. Its investment scope includes entities engaged in the research, development, production, distribution, or delivery of medical, dental, optical, pharmaceutical, or biotechnology products, supplies, equipment, or services. Furthermore, the fund employs equity derivatives, with a notable focus on writing options. Its portfolio's performance is gauged against the Russell 3000 Healthcare Index. Established on March 31, 2005, the fund is domiciled in the United States.